Skip to content
Search

Latest Stories

Pharmacy owner’s son jailed for selling PoM to criminal gangs

A pharmacy worker has been sentenced to six years in prison for selling prescription-only medicines (PoM) worth over £20 million to drug dealers.

David Ihenagwa, 40, of Edmonton, north London was sentenced by Croydon Crown Court last week (January 23), following a crackdown by the government’s Medicines and Healthcare products Regulatory Agency (MHRA).


Ihenagwa worked as a company secretary at his mother’s pharmacy in East London from where he supplied class B and class C controlled drugs to criminal gangs.

He pleaded guilty to one charge of supplying class B drugs and four charges of supplying class C drugs between September 2015 and April 2016, according to the government agency.

Ihenagwa's criminal activities were exposed when MHRA officials seized 13,440 Codeine Phosphate tablets from an address in Stoke-on-Trent in June 2016. The MHRA said those “were traced back to the pharmacy where Ihenagwa worked.”

The government agency found that the convicted pharmacy worker purchased the tablets from a licensed wholesale dealer in Surrey and operated his criminal enterprise from his mother’s pharmacy.

Its investigations showed that he regularly purchased far larger quantities of controlled drugs than would normally be dispensed from a high street pharmacy.

Further investigations revealed that Ihenagwa had sold medicines on at least 23 separate occasions to a criminal group: the drugs would be loaded in a van and shipped around the country by the gang.

Ihenagwa was charged with supplying large quantities of Codeine Phosphate, a class B drug, and class C drugs Diazepam, Zopiclone, Lorazepam, and Tramadol - all PoMs.

The MHRA said proceedings to confiscate the proceeds of Ihenagwa’s criminal activity were currently underway.

In a statement, Mark Jackson, MHRA Head of Enforcement, said: “Those who sell medicines illegally are exploiting vulnerable people and have no regard for their health. Prescription-only medicines are potent and should only be taken under medical supervision.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less